Did You Know...
...that after Walter Hunt patented the safety pin in 1849, he sold the rights to it for $400?
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6598603 | Method for treating respiratory diseases The invention provides a novel method of treating respiratory diseases, e.g., pediatric asthma, in a continuing regimen with not more than one daily dose of the drug budesonide using a nebulizer.... | 07/29/2003 |
| 6465213 | Nucleotide sequences The present invention relates to a nucleic acid molecule encoding a human or canine GABAB receptor, or a conservative variant thereof.... | 10/15/2002 |
| 6228373 | Peptides with immunomodulatory effects Peptides being absorbable by the epithelial cell lining in a mammal resulting in a modulated immune response and thereby a therapeutic effect against disease, formulations containing such peptides and uses thereof.... | 05/08/2001 |
| 6228374 | Peptides with immunomodulatory effects Novel homodimers that include cysteine-containing peptides having 4-15 amino acid residues can be administered to modulate the immune response in an animal.... | 05/08/2001 |
| 6192876 | Inhalation apparatus and method An apparatus for and a method of ensuring the fit of a face mask to the face of a patient, the apparatus including a face mask having an inlet through which gas can be inhaled and a sensor for measuring the flow rate of gas drawn through the inlet of the ... | 02/27/2001 |
| 6165976 | Therapeutic preparation for inhalation A therapeutic preparation for inhalation which comprises insulin and a substance which enhances the absorption of insulin in the lower respiratory tract, is provided in the form of a powder preparation suitable for inhalation.... | 12/26/2000 |
| 6075048 | Pediatric method of use of bambuterol New aqueous formulations of, and the paediatric use of, bambuterol, and of its pharmaceutically acceptable salts, are described.... | 06/13/2000 |
| 6045828 | Powders for inhalation A proliposome powder, said powder comprising in a single phase discrete particles of a biologically active component together with a lipid or mixture of lipids having a phase transition temperature of below 37° C. and a process for the manufacture of a p... | 04/04/2000 |
| 6043236 | Estrogens Compounds of the formula I ##STR1## a process for their preparation, their use in the treatment of autoimmune disorders as well as new intermediates for their preparation.... | 03/28/2000 |
| 6030604 | Formulation for inhalation A dry powder composition comprising one or more potent pharmaceutically active substances and a carrier substance, all of which are in finely divided form, wherein the formulation has a poured bulk density of from 0.28 to 0.38 g/ml is useful in the treatm... | 02/29/2000 |
| 6027714 | Formulation for inhalation A dry powder composition comprising budesonide and a carrier substance, both of which are in finely divided form, wherein the formulation has a poured bulk density of from 0.28 to 0.38 g/ml is useful in the treatment of respiratory disorders.... | 02/22/2000 |
| 6004574 | Powder formulations containing melezitose as a diluent A powder formulation for the administration of medically useful polypeptides, comprising a medically useful polypeptide with melezitose as diluent.... | 12/21/1999 |
| 5983956 | Formulation for inhalation A dry powder composition comprising formoterol and a carrier substance, both of which are in finely divided form, wherein the formulation has a poured bulk density of from 0.28 to 0.38 g/ml is useful in the treatment of respiratory disorders.... | 11/16/1999 |
| 5980949 | Formulation for inhalation A dry powder composition comprising terbutaline sulphate and a carrier substance, both of which are in finely divided form, wherein the formulation has a poured bulk density of from 0.28 to 0.38 g/ml is useful in the treatment of respiratory disorders.... | 11/09/1999 |
| 5955433 | Method of thrombin inhibition A method of inhibiting thrombin is disclosed, as well as a method of treating or preventing thrombosis and hypercoaguability. The methods employ compounds of the formula ##STR1## stereoisomers thereof and physiologically acceptable salts thereof.... | 09/21/1999 |
| 5885985 | Guanidine derivatives useful in therapy Guanidine derivatives of formula I ##STR1## wherein R8 represents hydrogen, halogen, alkyl C1 to 6, nitro, trifluoromethyl, thioalkyl C1 to 6, hydroxy, alkoxy C1 to 6, or a group selected from --NR4 R5, --O(CH2 | 03/23/1999 |
| 5843465 | Emulsion formulation The present invention is related to a pharmaceutical formulation which is an oil-in-water emulsion for parenteral and oral use which comprises (i) an emulsion-stabilizing surface active drug in high concentration; (ii) optionally a pharmacologically inert oil; (iii... | 12/01/1998 |
